Magnetar Capital, LLC is a privately owned alternative asset management firm founded in April 2005 and headquartered in Evanston, Illinois. The firm specializes in investing across various asset classes, including public equity, fixed income, corporate credit, real estate, and energy-related assets. Magnetar Capital employs a blend of fundamental and quantitative analysis to identify unique investment opportunities and aims to deliver consistent, long-term, risk-adjusted returns. The firm's investment strategies encompass global event-driven, fixed income, energy, and quantitative approaches. In addition to its headquarters, Magnetar Capital has satellite offices in major cities including New York, Philadelphia, London, and Beijing, enhancing its capacity to source and manage investments around the world.
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
CoreWeave
Series C in 2024
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
Comtech Telecommunications
Post in 2024
Comtech Telecommunications is a provider of advanced communications solutions, specializing in the design, development, production, and marketing of innovative products and systems. The company operates through two primary segments: Satellite and Space Communications, and Terrestrial and Wireless Networks, with the majority of its sales generated from the Satellite and Space Communications segment. Comtech has experienced significant growth in recent years and is positioned for continued advancement in the communications industry.
CoreWeave
Debt Financing in 2023
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
CoreWeave
Series B in 2023
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
CoreWeave
Series B in 2023
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
Arcadia
Venture Round in 2022
Arcadia, Inc. is a technology company focused on providing access to clean energy through its online platform. Founded in 2014 and based in Washington, D.C., the company connects users—ranging from residential homes to businesses—with renewable energy sources, such as wind farms and community solar projects. Its application enables users to manage their accounts, track energy usage, and participate in clean energy initiatives in their area. By democratizing access to energy data from over 125 utilities across the United States, Arcadia empowers consumers to transition away from fossil fuels and supports efforts to address energy inequality. The company also operates a leading community solar program, which contributes significantly to renewable energy generation while promoting economic growth.
CoreWeave
Debt Financing in 2022
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
Activ Surgical
Series B in 2022
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.
Enable Injections
Series C in 2022
Enable Injections, LLC specializes in the design and manufacture of disposable, body-worn bolus injectors that facilitate the delivery of high viscosity and volume injectable drugs directly into subcutaneous tissue. Established in 2010 and based in Cincinnati, Ohio, the company’s innovative devices can utilize standard containers such as vials, syringes, or cartridges. These injectors not only allow for the reconstitution of powdered drugs but also enable the delivery of up to 20 ml of medication. The system automatically warms and mixes lyophilized solutions, ensuring a seamless injection experience. Additionally, Enable Injections offers a version of its platform that can connect to smartphones via Bluetooth, enhancing user interaction. With approximately 900 new drugs in development that may benefit from this technology, the market for bolus injection systems is projected to reach $8 billion within the next decade.
Comtech Telecommunications
Post in 2021
Comtech Telecommunications is a provider of advanced communications solutions, specializing in the design, development, production, and marketing of innovative products and systems. The company operates through two primary segments: Satellite and Space Communications, and Terrestrial and Wireless Networks, with the majority of its sales generated from the Satellite and Space Communications segment. Comtech has experienced significant growth in recent years and is positioned for continued advancement in the communications industry.
Activ Surgical
Series B in 2021
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.
Benson Hill
Venture Round in 2021
Benson Hill is a crop improvement company that unlocks the natural diversity of plants and empowers innovators with a revolutionary crop design platform to develop healthier and more sustainable food and ingredients. Benson Hill empowers innovators to develop more healthy, flavorful, and sustainable food by unlocking the natural genetic diversity of plants. Benson Hill’s CropOS™ platform combines machine learning and big data with breeding techniques and plant biology to drastically accelerate and simplify the product development process.
Vedanta Biosciences
Series D in 2021
Vedanta Biosciences, Inc. is a clinical-stage microbiome company based in Cambridge, Massachusetts, focused on developing therapies for immune-mediated and infectious diseases using human microbiome-derived bacteria. Established in 2010, the company utilizes microbial ecology and mucosal immunology to create innovative immunotherapies. Its platform includes a comprehensive library of bacteria sourced from the human microbiome, proprietary assays for selecting effective bacterial strains, and extensive datasets from human interventional studies. Vedanta also possesses cGMP-compliant manufacturing capabilities, allowing for the production of defined bacterial consortia in powder form. This enables the development of oral therapies aimed at treating autoimmune and inflammatory diseases, providing physicians with effective access to live bacterial drugs. Vedanta operates as a subsidiary of Pure Tech Health plc.
Evolv Technology
Post in 2021
Evolv Technology specializes in AI-based touchless security screening systems that prioritize safety while enhancing the visitor experience. The company's Mosaiq Platform integrates real-time video surveillance with advanced detection capabilities for firearms and explosives, facial recognition, and security analytics, all designed to minimize false alarms. Headquartered in Waltham, Massachusetts, Evolv is led by professionals with extensive backgrounds in security, including experience with the TSA, FBI, CIA, Secret Service, and Homeland Security. The firm offers its products through direct sales and a multi-year security-as-a-service subscription model, which not only provides ongoing value to clients but also fosters predictable revenue streams and opportunities for expansion. Evolv Technology aims to protect both public and private sectors by securing soft targets and vital assets.
OncoResponse
Series C in 2021
OncoResponse Inc. is a Houston-based immuno-oncology company focused on discovering innovative cancer therapies through its proprietary human antibody platform. The company specializes in identifying fully human monoclonal antibodies that target high-value immuno-oncology targets, particularly those associated with immunosuppressive myeloid biology. By exploring the adaptive immune responses of cancer patients who have successfully undergone checkpoint inhibition, OncoResponse aims to develop therapeutic antibodies that can mitigate tumor microenvironment immunosuppression and enhance immune activation. This approach seeks to transform cold tumors into hot tumors, thereby improving treatment outcomes for cancer patients.
Judo Bank
Series D in 2020
Judo Bank is an Australian financial institution dedicated to providing tailored lending solutions to small and medium-sized enterprises (SMEs). Recognizing the vital role SMEs play in the Australian economy, Judo Bank offers a range of products, including business loans, equipment finance, lines of credit, and home loans. The bank emphasizes a relationship-driven approach, allowing customers to interact directly with decision-makers who assess each application based on its unique merits. This strategy contrasts with traditional banking processes that often overlook the specific needs of businesses. Judo Bank also sources funding through personal, business, and self-managed superannuation fund term deposits. With a commitment to integrity and customer service, Judo Bank aims to support SMEs effectively, ensuring they receive the attention and resources necessary to thrive.
Imvax
Series C in 2020
Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing patient-specific vaccines and immunotherapy strategies for treating malignant gliomas and other cancers. Founded in 2015, Imvax's key product, IGV-001, is an autologous tumor cell vaccine designed to harness the patient’s immune system to mount a comprehensive attack on tumor cells. The company employs advanced methodologies, including patient cell harvesting, treatment and implantation, as well as strategies that promote immunogenic cell death and activate both the innate and adaptive immune responses. By addressing unmet medical needs in cancer therapy, Imvax aims to provide innovative treatment options for patients suffering from challenging malignancies.
Imvax
Series B in 2019
Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing patient-specific vaccines and immunotherapy strategies for treating malignant gliomas and other cancers. Founded in 2015, Imvax's key product, IGV-001, is an autologous tumor cell vaccine designed to harness the patient’s immune system to mount a comprehensive attack on tumor cells. The company employs advanced methodologies, including patient cell harvesting, treatment and implantation, as well as strategies that promote immunogenic cell death and activate both the innate and adaptive immune responses. By addressing unmet medical needs in cancer therapy, Imvax aims to provide innovative treatment options for patients suffering from challenging malignancies.
Exo
Series B in 2019
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.
Lucid Energy Group
Private Equity Round in 2017
LUCID ENERGY GROUP is a midstream services company providing gathering, treating, processing, compression and transportation services to producers working in the Permian Basin. LUCID has developed and is continuing to expand its greenfield gathering and processing facilities in the high-growth production areas of the Wolfcamp and Clines shales. LUCID was formed in 2011 with equity commitments from EnCap Flatrock Midstream of San Antonio. Headquartered in Dallas, LUCID is focusing its operations on the Eastern Shelf region of the Permian Basin and has field offices near its operating assets in Sterling City and San Angelo. The company's ability to create unique solutions distinguishes LUCID and puts the company in a strong position to meet the accelerating demand for midstream infrastructure in the region. At LUCID, they understand how important service is to our customers. They hold fast to their vision and creativity. They believe in communicating clearly so that every deal is easily understood. They are perceptive and in the moment with our customers while we work hard to develop unconventional solutions and partner with them for success. Their customers trust them because there are no surprises. At LUCID, they are Vision At Work.
Fountainhead Commercial Capital
Series A in 2016
A key way for owners of small and midsized businesses to truly be successful and increase their net worth is to own their commercial real estate. Most people think that the dream of commercial property ownership is difficult and expensive, with large down payments and high, variable interest rates. With cash being such an important asset for any company, many business owners cannot afford to spend so much of their hard-earned capital to purchase their commercial property, even though they know what a great long-term investment owning their own property will be.
MPLX LP
Post in 2016
MPLX LP (MPLX) began trading on NYSE on October 26, 2012 and is a master limited partnership formed by Marathon Petroleum Corporation (MPC). The company’s assets consist of a network of common carrier crude oil and product pipeline systems, and associated crude oil and product storage assets in the Midwest and Gulf Coast regions of the U.S. MPLX owns, leases or has ownership interest in approximately 2,900 miles of pipeline across nine states. This network of petroleum pipelines is one of the largest in the U.S., based on total annual volumes delivered.
SurgRx
Series F in 2007
SurgRx is a developer of laparoscopic vessel fusion tools for surgical hemostasis.
Kintera
Post in 2006
Kintera is leader and pioneering provider of Software as a Service (SaaS) solutions to the nonprofit and government sectors. They are a leading provider of software that enables nonprofit organizations to use the Internet to bring their employees, volunteers and donors together in online, interactive communities that increase donations, reduce fundraising costs and build affinity for an organization's cause.
PosiGen
PosiGen is a provider of residential renewable energy and energy efficiency solutions aimed at low- to moderate-income homeowners. The company specializes in offering solar photovoltaic (PV) panel systems alongside energy efficiency retrofits, enabling customers to lower their utility bills and achieve financial autonomy. By focusing on underserved communities, PosiGen seeks to enhance energy independence and reduce reliance on traditional utility services. Through its commitment to affordable renewable energy, PosiGen aims to empower individuals and families, helping them to manage energy consumption and achieve greater fiscal stability.
TensorWave
TensorWave enables enterprises to harness the power of artificial intelligence and create innovative AI-based software.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.